Gilbert SM - Search Results

1

Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.

Gilbert SM, Dunn RL, Hollenbeck BK, Montie JE, Lee CT, Wood DP, Wei JT. Gilbert SM, et al. J Urol. 2010 May;183(5):1764-9. doi: 10.1016/j.juro.2010.01.013. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299056

2

Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.

Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS. Gilbert SM, et al. Urology. 2003 Mar;61(3):539-43. doi: 10.1016/s0090-4295(02)02400-7. Urology. 2003. PMID: 12639642 Clinical Trial.

3

Metabolic consequences and long-term complications of enterocystoplasty in children: a review.

Gilbert SM, Hensle TW. Gilbert SM, et al. J Urol. 2005 Apr;173(4):1080-6. doi: 10.1097/01.ju.0000155248.57049.4e. J Urol. 2005. PMID: 15758705 Review.

4

Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsies.

Gilbert SM, Cavallo CB, Kahane H, Lowe FC. Gilbert SM, et al. Urology. 2005 Mar;65(3):549-53. doi: 10.1016/j.urology.2004.10.064. Urology. 2005. PMID: 15780374

5

Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.

Gilbert SM, Murphy AM, Katz AE, Goluboff ET, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM. Gilbert SM, et al. Urology. 2006 Aug;68(2):287-91. doi: 10.1016/j.urology.2006.02.012. Urology. 2006. PMID: 16904438

6

A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.

Gilbert SM, Lee CT. Gilbert SM, et al. Nat Clin Pract Urol. 2006 Dec;3(12):675-9. doi: 10.1038/ncpuro0655. Nat Clin Pract Urol. 2006. PMID: 17149384 Review.

7

Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).

Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT. Gilbert SM, et al. Cancer. 2007 May 1;109(9):1756-62. doi: 10.1002/cncr.22556. Cancer. 2007. PMID: 17366596 Free article.

8

Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978.

Gilbert SM, Dunn RL, Wei JT. Gilbert SM, et al. J Urol. 2007 Apr;177(4):1584-5; author reply 1585. doi: 10.1016/j.juro.2006.11.053. J Urol. 2007. PMID: 17382782 No abstract available.

9

Getting under the hood of the volume-outcome relationship for radical cystectomy.

Hollenbeck BK, Daignault S, Dunn RL, Gilbert S, Weizer AZ, Miller DC. Hollenbeck BK, et al. J Urol. 2007 Jun;177(6):2095-9; discussion 2099. doi: 10.1016/j.juro.2007.01.153. J Urol. 2007. PMID: 17509295

10

Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.

Weizer AZ, Shah RB, Lee CT, Gilbert SM, Daignault S, Montie JE, Wood DP Jr. Weizer AZ, et al. Among authors: gilbert sm. Urol Oncol. 2007 Nov-Dec;25(6):460-4. doi: 10.1016/j.urolonc.2006.09.016. Urol Oncol. 2007. PMID: 18047952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters